Malignant Melanomas
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas (NCT05928962) | Fujian Cancer Hospital | 2022-10-27 |
Track Malignant Melanomas automatically
Every clearance here is in the API, with alerts when new ones post.